Bilal A. Siddiqui

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment”.

Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002919

N/A

1.6DataRank · unranked

56 citations

Bilal A. Siddiqui, Ana M. Aparicio, Shalini S. Yadav, Sreyashi Basu, Hong Chen +8 more

Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006262

N/A

0.449DataRank · unranked

19 citations

Brian F. Chapin, Sonali Jindal, Fei Duan, Sreyashi Basu, Shalini S. Yadav +16 more

Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistance

Signal Transduction and Targeted Therapy(2025)10.1038/s41392-025-02410-9

N/A

0.269DataRank · unranked

5 citations

Mohamed Altai, Katharina Lückerath, Wahed Zedan, Henan Zhu, Lars Breuer +26 more

Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial

European Urology(2025)10.1016/j.eururo.2025.07.006

N/A

0DataRank · unranked

24 citations

Bilal A. Siddiqui, Cara Haymaker, Bryan Fellman, Marina Nayeli Medina-Rosales, Tharakeswara Bathala +26 more

Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis

Cancer Immunology Research(2024)10.1158/2326-6066.cir-24-0011

N/A

0DataRank · unranked

15 citations

Nicolas L. Palaskas, Sreyashi Basu, Yibo Dai, Zhong He, Shalini S. Yadav +12 more

Cancer Cell–Extrinsic Roles for the Androgen Receptor in Prostate Cancer

Endocrinology(2023)10.1210/endocr/bqad078

N/A

0DataRank · unranked

15 citations

Bilal A. Siddiqui, Javier Leo, Eleonora Dondossola, Kaitlin J. Basham, Cindy K. Miranti +2 more

Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse Events

Journal of the National Comprehensive Cancer Network(2024)10.6004/jnccn.2023.7119

N/A

0DataRank · unranked

2 citations

Nicolas L. Palaskas, Bilal A. Siddiqui, Jennifer L. McQuade, Jamie S. Lin, Sumit K. Subudhi +8 more